{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:24:45Z","timestamp":1778711085957,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbadis.2018.07.030","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T16:36:19Z","timestamp":1533141379000},"page":"3397-3406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP)"],"prefix":"10.1016","volume":"1864","author":[{"given":"Michael","family":"Etscheid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saravanan","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnther","family":"Lochnit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Zabczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay-Martin","family":"Hanschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip M.","family":"Kanse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.07.030_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1538-7836.2008.03242.x","article-title":"Recommendations for nomenclature on fibrinogen and fibrin","volume":"7","author":"Medved","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0015","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1182\/blood-2010-08-300301","article-title":"Fibrinopeptides A and B release in the process of surface fibrin formation","volume":"117","author":"Riedel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0029-1234141","article-title":"Heritability of clot formation","volume":"35","author":"Standeven","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0030","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.20.5.1354","article-title":"Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy","volume":"20","author":"Collet","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0035","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000033221.73082.06","article-title":"Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease","volume":"106","author":"Mills","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0040","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0045","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0050","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1515\/BC.2002.121","article-title":"Factor VII activating protease (FSAP): a novel protease in hemostasis","volume":"383","author":"R\u00f6misch","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/ATVBAHA.111.238394","article-title":"Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor","volume":"32","author":"Kanse","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.thromres.2012.07.023","article-title":"The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity","volume":"130","author":"Etscheid","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.0000055189.18831.B1","article-title":"Marburg I polymorphism of factor VII\u2014activating protease: a prominent risk predictor of carotid stenosis","volume":"107","author":"Willeit","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0075","first-page":"424759","article-title":"Factor VII activating protease polymorphism (G534E) is associated with increased risk for stroke and mortality","volume":"2011","author":"Trompet","year":"2011","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0080","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1160\/TH04-05-0275","article-title":"The factor VII activating protease G511E (Marburg) variant and cardiovascular risk","volume":"92","author":"Ireland","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/hep.22707","article-title":"The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB","volume":"49","author":"Wasmuth","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.thromres.2012.02.009","article-title":"The G534E-polymorphism of the gene encoding the Factor VII-activating protease is a risk factor for venous thrombosis and recurrent events","volume":"130","author":"Ahmad-Nejad","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0095","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2004-08-3328","article-title":"Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism","volume":"105","author":"Hoppe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0100","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1182\/blood-2005-02-0576","article-title":"The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis","volume":"105","author":"van Minkelen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0105","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood-2005-09-3603","article-title":"Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism","volume":"107","author":"Franchi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH05-09-0601","article-title":"Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism","volume":"95","author":"Gulesserian","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1160\/TH06-12-0739","article-title":"The Marburg I polymorphism of factor VII-activating protease and the risk of venous thromboembolism","volume":"97","author":"Weisbach","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1160\/TH07-10-0607","article-title":"Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry","volume":"99","author":"Pecheniuk","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1160\/TH14-06-0519","article-title":"Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP)","volume":"113","author":"Subramaniam","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bcmd.2013.07.014","article-title":"Role of hepsin in factor VII activation in zebrafish","volume":"52","author":"Khandekar","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00001721-200207000-00008","article-title":"The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP)","volume":"13","author":"R\u00f6misch","year":"2002","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0140","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.4049\/jimmunol.1103029","article-title":"Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a","volume":"188","author":"Kanse","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1248\/bpb.24.140","article-title":"Identification of the substrates for plasma hyaluronan binding protein","volume":"24","author":"Choi-Miura","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0150","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0014-5793(99)00959-X","article-title":"Detection of a novel plasma serine protease during purification of vitamin K-dependent coagulation factors","volume":"456","author":"Hunfeld","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0155","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1538-7836.2012.04883.x","article-title":"An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values","volume":"10","author":"Pieters","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/jth.12174","article-title":"Elimination of coagulation factor XIII from fibrinogen preparations","volume":"11","author":"Smith","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ab.2013.04.012","article-title":"Factor XIIIa generation assay: a tool for studying factor XIII function in plasma","volume":"439","author":"Dodt","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0170","doi-asserted-by":"crossref","first-page":"18650","DOI":"10.1016\/S0021-9258(17)44801-0","article-title":"The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin","volume":"265","author":"Siebenlist","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0175","first-page":"292","article-title":"The FVII activating protease cleaves single-chain plasminogen activators","volume":"29","author":"R\u00f6misch","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.12229","article-title":"Fibrin(ogen) and thrombotic disease","volume":"11","author":"Ari\u00ebns","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2011.05.030","article-title":"Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo","volume":"409","author":"Yamamichi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0190","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1074\/jbc.M112.404301","article-title":"Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones","volume":"288","author":"Longstaff","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-3495(92)81594-1","article-title":"Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations. Clot structure and assembly are kinetically controlled","volume":"63","author":"Weisel","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0200","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/S0021-9258(18)89277-8","article-title":"Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene","volume":"260","author":"Liu","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0205","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2119\/molmed.2010.00146","article-title":"Novel aspects of fibrin(ogen) fragments during inflammation","volume":"17","author":"Jennewein","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm1198","article-title":"The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury","volume":"11","author":"Petzelbauer","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/9ae032a2-c48d-46d9-9f8f-d3f401714e42","article-title":"Peptide Bbeta(15-42) preserves endothelial barrier function in shock","volume":"4","author":"Gr\u00f6ger","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0225","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1160\/TH07-10-0640","article-title":"Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis","volume":"99","author":"Kanse","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0230","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1084\/jem.20052546","article-title":"The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation","volume":"203","author":"Sedding","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0235","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/ejn.12830","article-title":"Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice","author":"Joshi","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0240","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2005-05-2150","article-title":"The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis","volume":"106","author":"Collet","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0245","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","article-title":"Mechanisms of fibrin polymerization and clinical implications","volume":"121","author":"Weisel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0250","doi-asserted-by":"crossref","first-page":"19288","DOI":"10.1074\/jbc.271.32.19288","article-title":"Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking","volume":"271","author":"Sobel","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0255","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1021\/bi952294k","article-title":"Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen","volume":"35","author":"Matsuka","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0260","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1021\/bi00591a023","article-title":"Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites","volume":"18","author":"Cottrell","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0265","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1096\/fj.08-110429","article-title":"Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP)","volume":"22","author":"Zeerleder","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.07.030_bb0270","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/cc10131","article-title":"Activation of factor VII-activating protease in human inflammation: a sensor for cell death","volume":"15","author":"Stephan","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0275","doi-asserted-by":"crossref","first-page":"40107","DOI":"10.1021\/acsami.7b14281","article-title":"A positively charged surface triggers coagulation activation through factor VII activating protease (FSAP)","volume":"9","author":"Sperling","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbadis.2018.07.030_bb0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2017.11.012","article-title":"Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)","volume":"161","author":"Grasso","year":"2017","journal-title":"Thromb. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T16:18:40Z","timestamp":1661703520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918302795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0925443918302795"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.030","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP)","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}